• Explore /
  • Poster
  • / A phase II study of novel three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study).

A phase II study of novel three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study).

Abstract Poster

Authors

null

Hiroaki Tanaka

Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan

Hiroaki Tanaka , Nobuaki Suzuki , Haruo Iguchi , Kazuhiro Uesugi , Kosei Hirakawa , Ryosuke Amano , Atsushi Aruga , Takashi Hatori , Ishizaki Hidenobu , Yuzo Umeda , Mitsuo Shimada , Kazuhiko Yoshimatsu , Ryoichi Shimizu , Hiroaki Ozasa , Hiroto Hayashi , Koichiro Sakata , Tomio Ueno , Hiroyuki Furukawa , Shoichi Hazama , Masaaki Oka

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

UMIN000008082

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3045)

DOI

10.1200/jco.2015.33.15_suppl.3045

Abstract #

3045

Poster Bd #

371

Abstract Disclosures

Similar Posters

First Author: Syed A. Hussain

First Author: Ashwin Reddy Sama

Poster

2015 ASCO Annual Meeting

Phase 2 studies of multiple peptides cocktail vaccine for treatment-resistant cervical and ovarian cancer.

Phase 2 studies of multiple peptides cocktail vaccine for treatment-resistant cervical and ovarian cancer.

First Author: Satoshi Takeuchi

First Author: Alison Catherine Backen